Walmsley says GSK is “incredibly intentional” in how the company recruits and trains talent. The company’s management has worked on ways to reduce their rate of misses when ...

The decision wiped almost £7bn off GSK’s value in one day and has cast a cloud over Dame Emma’s tenure. Analysts described the Delaware ruling as a major surprise given a judge in Florida ...

GlaxoSmithKline would consider buying Pfizer’s consumer health business – but only if the price is right, according to the company's chief executive. Emma Walmsley has also been busy shaking ...

CEO Emma Walmsley said the company has been anticipating tariffs on the industry and is “confident” the company can navigate through it, Ashleigh Furlong and Ruth David of Bloomberg reports. The U.S.

GSK CEO Emma Walmsley’s $13 million salary is predicated on picking the right people to steer cutting-edge drug development for the world’s most challenging diseases. During her eight years at ...

Explore how U.S. tariffs and vaccine skepticism may impact GSK plc's profitability. Click for my update as tariffs are creating turbulence within the Pharma sector.

This month marks the start of a new era for GlaxoSmithKline, with Emma Walmsley ... hit the market this year, GSK said earnings will be flat, or decrease slightly. Walmsley, who used to head ...

GSK could double its long-serving CEO Emma Walmsley’s pay packet to £21.6 million ($27.2 million) after admitting its boss's current pay didn’t reward her performance and would put off future ...

GSK is betting on AI to boost innovation for ... but a balanced approach toward regulation is important, CEO Emma Walmsley says. Speaking at the CEO Times Summit in London, Walmsley highlights ...

GSK is studying a group of more than a million older adults in the UK to see if its shingles vaccine lowers the risk of dementia. The British drugs group, led by boss Emma Walmsley, is using the ...